In Case You Missed It: Three Things We Learned In Our World Preview Webinar
You may have read the report, you may have pondered the infographic, but the best way to really get under the skin of the Evaluate World Preview report is to join the webinar. As well as sharing the highlights of the data from the report, the webinar gave our presenters a chance to really discuss […]
Late to the Party? Prepare to Pay the Price
I saw a tweet recently asking “in recent years, what has become simultaneously worse and more expensive?”. One wag responded with “life”, but I’d also argue that investing in biopharma companies is a feasible answer. Bear with me. Before the recent slump put a downer on the markets, public and private investors had been backing […]
